− CHMP var enigt om, at der ikke var behov for begrænsninger for formuleringer til lokal anvendelse af piroxicam, og at benefit/ risk- forholdet fortsat er gunstigt -
− The CHMP agreed that no restrictions were required with regards to topical formulations of piroxicam and the benefit/ risk balance remains favourable.